177 related articles for article (PubMed ID: 12457151)
1. Radiocontrast nephropathy: the dye is not cast.
Lepor NE
Rev Cardiovasc Med; 2000; 1(1):43-54. PubMed ID: 12457151
[TBL] [Abstract][Full Text] [Related]
2. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
3. Radiocontrast-induced acute renal failure: allocations and outcomes.
Mehran R; Ashby DT
Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
Asif A; Epstein DL; Epstein M
J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
[TBL] [Abstract][Full Text] [Related]
5. Past and present attempts to prevent radiocontrast nephropathy.
Bailey SR
Rev Cardiovasc Med; 2001; 2 Suppl 1():S14-8. PubMed ID: 12439363
[TBL] [Abstract][Full Text] [Related]
6. [Nephropathy caused by radiocontrast media].
Kolarz M; Sułowicz W
Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
[TBL] [Abstract][Full Text] [Related]
7. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
Kini AA; Sharma SK
Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Madyoon H
Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
[TBL] [Abstract][Full Text] [Related]
9. [Contrast-induced acute renal failure].
Giannattasio M
G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
[TBL] [Abstract][Full Text] [Related]
10. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy.
Forman JP
N Engl J Med; 2004 Feb; 350(8):836-8; author reply 836-8. PubMed ID: 14978836
[No Abstract] [Full Text] [Related]
11. Contrast-induced nephropathy.
Pucelikova T; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
[TBL] [Abstract][Full Text] [Related]
12. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients.
Madyoon H; Croushore L; Weaver D; Mathur V
Catheter Cardiovasc Interv; 2001 Jul; 53(3):341-5. PubMed ID: 11458411
[TBL] [Abstract][Full Text] [Related]
13. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization.
Nunag M; Brogan M; Garrick R
Cardiol Rev; 2009; 17(6):263-9. PubMed ID: 19829174
[TBL] [Abstract][Full Text] [Related]
14. Radiocontrast-induced nephropathy.
Solomon R
Semin Nephrol; 1998 Sep; 18(5):551-7. PubMed ID: 9754608
[TBL] [Abstract][Full Text] [Related]
15. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
17. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
[TBL] [Abstract][Full Text] [Related]
18. Contrast nephropathy: review focusing on prevention.
Maeder M; Klein M; Fehr T; Rickli H
J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
[TBL] [Abstract][Full Text] [Related]
19. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Ng MK; Tremmel J; Fitzgerald PJ; Fearon WF
J Interv Cardiol; 2006 Feb; 19(1):75-9. PubMed ID: 16483344
[TBL] [Abstract][Full Text] [Related]
20. Contrast-associated nephropathy: presentation, pathophysiology and management.
Porter GA
Miner Electrolyte Metab; 1994; 20(4):232-43. PubMed ID: 7845325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
